β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects

KA Glen, IL Lamont - Pathogens, 2021 - mdpi.com
Pseudomonas aeruginosa is a major opportunistic pathogen, causing a wide range of acute
and chronic infections. β-lactam antibiotics including penicillins, carbapenems …

The two faces of cyanide: an environmental toxin and a potential novel mammalian gasotransmitter

K Zuhra, C Szabo - The FEBS journal, 2022 - Wiley Online Library
Cyanide is traditionally viewed as a cytotoxic agent, with its primary mode of action being the
inhibition of mitochondrial Complex IV (cytochrome c oxidase). However, recent studies …

Anti-inflammatory effect of lavender (Lavandula angustifolia Mill.) essential oil prepared during different plant phenophases on THP-1 macrophages

E Pandur, A Balatinácz, G Micalizzi, L Mondello… - … medicine and therapies, 2021 - Springer
Background Pseudomonas aeruginosa is the most common Gram-negative bacterium
associated with nosocomial respiratory infections. Lavender essential oil is mainly used in …

Antibacterial, Immunomodulatory, and Lung Protective Effects of Boswellia dalzielii Oleoresin Ethanol Extract in Pulmonary Diseases: In Vitro and In Vivo Studies

B Alotaibi, WA Negm, E Elekhnawy, TA El-Masry… - Antibiotics, 2021 - mdpi.com
Lung diseases such as asthma, chronic obstructive pulmonary diseases, and pneumonia
are causing many global health problems. The COVID-19 pandemic has directed the …

A 10-year microbiological study of Pseudomonas aeruginosa strains revealed the circulation of populations resistant to both carbapenems and quaternary …

M Pottier, F Gravey, S Castagnet, M Auzou… - Scientific Reports, 2023 - nature.com
Pseudomonas aeruginosa is one of the leading causes of healthcare-associated infections.
For this study, the susceptibility profiles to antipseudomonal antibiotics and a quaternary …

Ceftazidime/avibactam in ventilator-associated pneumonia due to difficult-to-treat non-fermenter Gram-negative bacteria in COVID-19 patients: a case series and …

GJ Burastero, G Orlando, A Santoro, M Menozzi… - Antibiotics, 2022 - mdpi.com
Ventilator-associated pneumonia (VAP) in critically ill patients with COVID-19 represents a
very huge global threat due to a higher incidence rate compared to non-COVID-19 patients …

Stability considerations for bacteriophages in liquid formulations designed for nebulization

R Flint, DR Laucirica, HK Chan, BJ Chang, SM Stick… - Cells, 2023 - mdpi.com
Pulmonary bacterial infections present a significant health risk to those with chronic
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …

[HTML][HTML] The gut microbiome is a significant risk factor for future chronic lung disease

Y Liu, SM Teo, G Méric, HHF Tang, Q Zhu… - Journal of Allergy and …, 2023 - Elsevier
Background The gut-lung axis is generally recognized, but there are few large studies of the
gut microbiome and incident respiratory disease in adults. Objectives To investigate the …

Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease

J Eklöf, TS Ingebrigtsen, R Sørensen, MI Saeed… - Thorax, 2022 - thorax.bmj.com
Background Inhaled corticosteroids (ICS) are commonly used to treat COPD and are
associated with increased risk of pneumonia. The aim of this study was to assess if …

A role for the stringent response in ciprofloxacin resistance in Pseudomonas aeruginosa

L García-Villada, NP Degtyareva, AM Brooks… - Scientific Reports, 2024 - nature.com
Pseudomonas aeruginosa is a major cause of nosocomial infections and the leading cause
of chronic lung infections in cystic fibrosis and chronic obstructive pulmonary disease …